Delivery Sciences News Today

Numbers here tomorrow. Apples worse day in seven months. Apple now moving higher in the premarket. Yum sales take a hit in china after food safety scares, numbers from costco, and nevada lays out the welcome mat for musk, the 5 billion factory going to the desert. Ecb cut Interest Rates to new record lows in effort to ward off deflation, lowering the rate by a tenth percent, and its rate on bank overnight deposits to negative. 2 . The president says the bank will purchase asset backed securities...

JUPITER, Fla. & DURHAM - Ligand Pharmaceuticals today announced the launch of Pelthos Therapeutics , a biopharmaceutical company, and the appointment of seasoned industry executive Scott Plesha to...

/PRNewswire/ -- Ademi LLP is investigating BioDelivery Sciences (NASDAQ: BDSI) for possible breaches of fiduciary duty and other violations of law in its...

Collegium Pharmaceutical Inc (NASDAQ:COLL) will acquire BioDelivery Sciences International Inc (NASDAQ:BDSI) at $5.60 per share in ...

Markets opened lower on Monday morning, but nothing held these two companies back.

Shares of the small pharmaceutical company, which focuses on pain management, have been rising since it released updated guidance late last week.

Top Biotech Stocks to Buy for 2021 TheStreet 3/2/2021 © TheStreet Top Biotech Stocks to Buy for 2021 Investing in biotech can be a bit of an experiment: I have profiled several small-cap biotech stocks that have grown into real monsters, and others that have gone dormant. The former include stocks such as Axsome Therapeutics , Reata Pharmaceuticals and Invitae . The latter includes Synergy Pharma . This is basically the roller coaster an investor can expect from this high-beta segment of...

Top Biotech Stocks to Buy for 2021 TheStreet 3/2/2021 © TheStreet Top Biotech Stocks to Buy for 2021 Investing in biotech can be a bit of an experiment: I have profiled several small-cap biotech stocks that have grown into real monsters, and others that have gone dormant. The former include stocks such as Axsome Therapeutics , Reata Pharmaceuticals and Invitae . The latter includes Synergy Pharma . This is basically the roller coaster an investor can expect from this high-beta segment of...